Form D · Biotechnology
LABGENIUS Ltd
London, X0 · CIK 0001718254
Offering snapshot reported Oct 12, 2017 · SEC filing
- Reported sold
- $2.77M Offering amount: $2.77M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2017 | Initial | $2,772,778 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-296479
Source: Form D, filed Oct 12, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Field | Director, Executive |
| Harrison Rickerby | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Suite 1, 3 Rd Floor 11 12 St. James's Square
London, X0, SW1Y 4LB
London, X0, SW1Y 4LB